抗血栓治疗-话题@MedSci

#抗血栓治疗#

27篇内容 | 2327人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1385518, encodeId=6c09138551828, content=<a href='/topic/show?id=1ea455e6064' target=_blank style='color:#2F92EE;'>#抗血栓治疗#</a>, objectTitle=Eur Heart J：AF患者PCI后抗血栓治疗，双重还是三重？, objectType=article, longId=141257, objectId=772c14125e23, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=772c14125e23, replyNumber=0, likeNumber=69, createdTime=2018-06-23, rootId=0, userName=wsusan1966, userId=ef33504, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=772c14125e23, moduleTitle=Eur Heart J：AF患者PCI后抗血栓治疗，双重还是三重？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=772c14125e23)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1385517, encodeId=85d6138551e92, content=<a href='/topic/show?id=1ea455e6064' target=_blank style='color:#2F92EE;'>#抗血栓治疗#</a>, objectTitle=Eur J Clin Pharmacol：哪些因素影响房颤患者预防卒中的抗血栓治疗决策？, objectType=article, longId=120369, objectId=990812036991, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=990812036991, replyNumber=0, likeNumber=88, createdTime=2017-11-18, rootId=0, userName=wsusan1966, userId=ef33504, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=990812036991, moduleTitle=Eur J Clin Pharmacol：哪些因素影响房颤患者预防卒中的抗血栓治疗决策？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=990812036991)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1385516, encodeId=83231385516c0, content=<a href='/topic/show?id=1ea455e6064' target=_blank style='color:#2F92EE;'>#抗血栓治疗#</a>, objectTitle=NEJM：房颤患者PCI后双抗还是三重抗血栓治疗更好？, objectType=article, longId=119427, objectId=a68511942e0c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a68511942e0c, replyNumber=0, likeNumber=118, createdTime=2017-11-11, rootId=0, userName=wsusan1966, userId=ef33504, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a68511942e0c, moduleTitle=NEJM：房颤患者PCI后双抗还是三重抗血栓治疗更好？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a68511942e0c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1385515, encodeId=ff1b138551543, content=<a href='/topic/show?id=1ea455e6064' target=_blank style='color:#2F92EE;'>#抗血栓治疗#</a>, objectTitle=JACC：经导管主动脉瓣置换术后阿司匹林与阿司匹林加氯吡格雷抗血栓治疗的比较, objectType=article, longId=104556, objectId=28d310455605, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28d310455605, replyNumber=0, likeNumber=78, createdTime=2017-07-06, rootId=0, userName=wsusan1966, userId=ef33504, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28d310455605, moduleTitle=JACC：经导管主动脉瓣置换术后阿司匹林与阿司匹林加氯吡格雷抗血栓治疗的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28d310455605)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1385514, encodeId=76631385514dc, content=<a href='/topic/show?id=1ea455e6064' target=_blank style='color:#2F92EE;'>#抗血栓治疗#</a>, objectTitle=Ann Intern Med：原发性血小板增多症抗血栓治疗的益处和风险！, objectType=article, longId=104445, objectId=f1ee10444578, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1ee10444578, replyNumber=0, likeNumber=72, createdTime=2017-07-05, rootId=0, userName=wsusan1966, userId=ef33504, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1ee10444578, moduleTitle=Ann Intern Med：原发性血小板增多症抗血栓治疗的益处和风险！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1ee10444578)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1385513, encodeId=2634138551318, content=<a href='/topic/show?id=1ea455e6064' target=_blank style='color:#2F92EE;'>#抗血栓治疗#</a>, objectTitle=Nat Commun：抗血栓治疗新突破：新型小分子可成功防血栓，避免异常出血！, objectType=article, longId=100423, objectId=60e5100423cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60e5100423cf, replyNumber=0, likeNumber=0, createdTime=2017-06-03, rootId=0, userName=wsusan1966, userId=ef33504, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60e5100423cf, moduleTitle=Nat Commun：抗血栓治疗新突破：新型小分子可成功防血栓，避免异常出血！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60e5100423cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1385512, encodeId=09b91385512bf, content=<a href='/topic/show?id=1ea455e6064' target=_blank style='color:#2F92EE;'>#抗血栓治疗#</a>, objectTitle=Cochrane DB Syst Rev：急性缺血性卒中后LMWHs抗血栓治疗的“是是非非”, objectType=article, longId=97777, objectId=4c9f9e777ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4c9f9e777ac, replyNumber=0, likeNumber=107, createdTime=2017-05-04, rootId=0, userName=wsusan1966, userId=ef33504, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4c9f9e777ac, moduleTitle=Cochrane DB Syst Rev：急性缺血性卒中后LMWHs抗血栓治疗的“是是非非”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4c9f9e777ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1385511, encodeId=aa971385511b5, content=<a href='/topic/show?id=1ea455e6064' target=_blank style='color:#2F92EE;'>#抗血栓治疗#</a>, objectTitle=Cochrane Database Syst Rev：急性缺血性卒中后LMWHs抗血栓治疗的“是是非非”, objectType=article, longId=97760, objectId=2dd39e7608b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2dd39e7608b, replyNumber=0, likeNumber=89, createdTime=2017-05-04, rootId=0, userName=wsusan1966, userId=ef33504, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2dd39e7608b, moduleTitle=Cochrane Database Syst Rev：急性缺血性卒中后LMWHs抗血栓治疗的“是是非非”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2dd39e7608b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1385510, encodeId=b273138551088, content=<a href='/topic/show?id=1ea455e6064' target=_blank style='color:#2F92EE;'>#抗血栓治疗#</a>, objectTitle=2015EHRA立场文件——接受心脏电生理手术患者的抗血栓治疗发布, objectType=article, longId=78469, objectId=aa4fe846957, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa4fe846957, replyNumber=0, likeNumber=60, createdTime=2016-09-27, rootId=0, userName=wsusan1966, userId=ef33504, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa4fe846957, moduleTitle=2015EHRA立场文件——接受心脏电生理手术患者的抗血栓治疗发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aa4fe846957)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1385509, encodeId=af1f138550928, content=<a href='/topic/show?id=1ea455e6064' target=_blank style='color:#2F92EE;'>#抗血栓治疗#</a>, objectTitle=Stroke：有卒中危险因素的人群行抗血栓治疗，可改善卒中后预后, objectType=article, longId=73767, objectId=70ffe3767c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70ffe3767c9, replyNumber=0, likeNumber=69, createdTime=2016-07-27, rootId=0, userName=wsusan1966, userId=ef33504, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70ffe3767c9, moduleTitle=Stroke：有卒中危险因素的人群行抗血栓治疗，可改善卒中后预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70ffe3767c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1385508, encodeId=72b113855086e, content=<a href='/topic/show?id=1ea455e6064' target=_blank style='color:#2F92EE;'>#抗血栓治疗#</a>, objectTitle=Stroke：心房纤颤患者急性脑缺血性卒中后的抗血栓治疗, objectType=article, longId=42389, objectId=abf4423898b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=abf4423898b, replyNumber=0, likeNumber=67, createdTime=2014-11-12, rootId=0, userName=wsusan1966, userId=ef33504, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=abf4423898b, moduleTitle=Stroke：心房纤颤患者急性脑缺血性卒中后的抗血栓治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=abf4423898b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

抗血栓治疗

2020-05-29

wsusan1966 (审核中...)

前往app查看评论内容

#抗血栓治疗#

Eur Heart J：AF患者PCI后抗血栓治疗，双重还是三重？

2018-06-23

wsusan1966 (审核中...)

前往app查看评论内容

#抗血栓治疗#

Eur J Clin Pharmacol：哪些因素影响房颤患者预防卒中的抗血栓治疗决策？

2017-11-18

wsusan1966 (审核中...)

前往app查看评论内容

#抗血栓治疗#

NEJM：房颤患者PCI后双抗还是三重抗血栓治疗更好？

2017-11-11

wsusan1966 (审核中...)

前往app查看评论内容

#抗血栓治疗#

JACC：经导管主动脉瓣置换术后阿司匹林与阿司匹林加氯吡格雷抗血栓治疗的比较

2017-07-06

wsusan1966 (审核中...)

前往app查看评论内容

#抗血栓治疗#

Ann Intern Med：原发性血小板增多症抗血栓治疗的益处和风险！

2017-07-05

wsusan1966 (审核中...)

前往app查看评论内容

#抗血栓治疗#

Nat Commun：抗血栓治疗新突破：新型小分子可成功防血栓，避免异常出血！

2017-06-03

wsusan1966 (审核中...)

前往app查看评论内容

#抗血栓治疗#

Cochrane DB Syst Rev：急性缺血性卒中后LMWHs抗血栓治疗的“是是非非”

2017-05-04

wsusan1966 (审核中...)

前往app查看评论内容

#抗血栓治疗#

Cochrane Database Syst Rev：急性缺血性卒中后LMWHs抗血栓治疗的“是是非非”

2017-05-04

wsusan1966 (审核中...)

前往app查看评论内容

#抗血栓治疗#

2015EHRA立场文件——接受心脏电生理手术患者的抗血栓治疗发布

2016-09-27

wsusan1966 (审核中...)

前往app查看评论内容

#抗血栓治疗#

Stroke：有卒中危险因素的人群行抗血栓治疗，可改善卒中后预后

2016-07-27

wsusan1966 (审核中...)

前往app查看评论内容

#抗血栓治疗#

Stroke：心房纤颤患者急性脑缺血性卒中后的抗血栓治疗

2014-11-12

科室
- - 订阅+
  - 更多科室
工具
服务